• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

补体介导的 IL-17A 轴调节是实验性变应性哮喘严重程度的主要遗传决定因素。

Complement-mediated regulation of the IL-17A axis is a central genetic determinant of the severity of experimental allergic asthma.

机构信息

Division of Immunobiology, Cincinnati Children's Hospital Medical Center, Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.

出版信息

Nat Immunol. 2010 Oct;11(10):928-35. doi: 10.1038/ni.1926. Epub 2010 Aug 29.

DOI:10.1038/ni.1926
PMID:20802484
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2943538/
Abstract

Severe asthma is associated with the production of interleukin 17A (IL-17A). The exact role of IL-17A in severe asthma and the factors that drive its production are unknown. Here we demonstrate that IL-17A mediated severe airway hyperresponsiveness (AHR) in susceptible strains of mice by enhancing IL-13-driven responses. Mechanistically, we demonstrate that IL-17A and AHR were regulated by allergen-driven production of anaphylatoxins, as mouse strains deficient in complement factor 5 (C5) or the complement receptor C5aR mounted robust IL-17A responses, whereas mice deficient in C3aR had fewer IL-17-producing helper T cells (T(H)17 cells) and less AHR after allergen challenge. The opposing effects of C3a and C5a were mediated through their reciprocal regulation of IL-23 production. These data demonstrate a critical role for complement-mediated regulation of the IL-23-T(H)17 axis in severe asthma.

摘要

严重哮喘与白细胞介素 17A(IL-17A)的产生有关。IL-17A 在严重哮喘中的确切作用及其产生的驱动因素尚不清楚。在这里,我们证明 IL-17A 通过增强 IL-13 驱动的反应,介导了易感小鼠的严重气道高反应性(AHR)。从机制上讲,我们证明 IL-17A 和 AHR 受到过敏原驱动的过敏毒素产生的调节,因为补体因子 5(C5)或补体受体 C5aR 缺失的小鼠表现出强烈的 IL-17A 反应,而 C3aR 缺失的小鼠在过敏原挑战后产生的 IL-17 产生辅助性 T 细胞(T(H)17 细胞)和 AHR 较少。C3a 和 C5a 的相反作用是通过它们对 IL-23 产生的相互调节来介导的。这些数据表明补体介导的 IL-23-T(H)17 轴的调节在严重哮喘中起关键作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8846/2943538/d95f996b345a/nihms225883f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8846/2943538/423d93977df1/nihms225883f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8846/2943538/6026bf7e8db6/nihms225883f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8846/2943538/ac1532bae977/nihms225883f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8846/2943538/6b2f66bea41c/nihms225883f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8846/2943538/b2446f9d321a/nihms225883f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8846/2943538/1e5a5d1715ef/nihms225883f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8846/2943538/24ac3e7477b7/nihms225883f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8846/2943538/d95f996b345a/nihms225883f8.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8846/2943538/423d93977df1/nihms225883f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8846/2943538/6026bf7e8db6/nihms225883f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8846/2943538/ac1532bae977/nihms225883f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8846/2943538/6b2f66bea41c/nihms225883f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8846/2943538/b2446f9d321a/nihms225883f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8846/2943538/1e5a5d1715ef/nihms225883f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8846/2943538/24ac3e7477b7/nihms225883f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8846/2943538/d95f996b345a/nihms225883f8.jpg

相似文献

1
Complement-mediated regulation of the IL-17A axis is a central genetic determinant of the severity of experimental allergic asthma.补体介导的 IL-17A 轴调节是实验性变应性哮喘严重程度的主要遗传决定因素。
Nat Immunol. 2010 Oct;11(10):928-35. doi: 10.1038/ni.1926. Epub 2010 Aug 29.
2
Distinct roles of the anaphylatoxins C3a and C5a in dendritic cell-mediated allergic asthma.过敏毒素C3a和C5a在树突状细胞介导的过敏性哮喘中的不同作用
J Immunol. 2014 Dec 1;193(11):5387-401. doi: 10.4049/jimmunol.1400080. Epub 2014 Oct 29.
3
Pharmacological targeting of anaphylatoxin receptors during the effector phase of allergic asthma suppresses airway hyperresponsiveness and airway inflammation.在过敏性哮喘效应阶段对过敏毒素受体进行药物靶向治疗可抑制气道高反应性和气道炎症。
J Immunol. 2005 Jan 15;174(2):783-9. doi: 10.4049/jimmunol.174.2.783.
4
Mast cell anaphylatoxin receptor expression can enhance IgE-dependent skin inflammation in mice.肥大细胞过敏毒素受体表达可增强小鼠 IgE 依赖性皮肤炎症。
J Allergy Clin Immunol. 2013 Feb;131(2):541-8.e1-9. doi: 10.1016/j.jaci.2012.05.009. Epub 2012 Jun 22.
5
Complement factor C5 inhibition reduces type 2 responses without affecting group 2 innate lymphoid cells in a house dust mite induced murine asthma model.补体因子 C5 抑制作用可减少 2 型反应,而不影响屋尘螨诱导的小鼠哮喘模型中的 2 类先天淋巴细胞。
Respir Res. 2019 Jul 24;20(1):165. doi: 10.1186/s12931-019-1136-5.
6
Evidence for anti-inflammatory effects of C5a on the innate IL-17A/IL-23 axis.C5a 对先天 IL-17A/IL-23 轴的抗炎作用的证据。
FASEB J. 2012 Apr;26(4):1640-51. doi: 10.1096/fj.11-199216. Epub 2011 Dec 27.
7
Diesel exhaust particle induction of IL-17A contributes to severe asthma.柴油机废气颗粒诱导白细胞介素-17A 导致严重哮喘。
J Allergy Clin Immunol. 2013 Nov;132(5):1194-1204.e2. doi: 10.1016/j.jaci.2013.06.048. Epub 2013 Sep 20.
8
IFN-gamma and IL-17 production in experimental autoimmune encephalomyelitis depends on local APC-T cell complement production.实验性自身免疫性脑脊髓炎中干扰素-γ和白细胞介素-17的产生取决于局部抗原呈递细胞- T细胞补体的产生。
J Immunol. 2008 May 1;180(9):5882-9. doi: 10.4049/jimmunol.180.9.5882.
9
A regulatory role for the C5a anaphylatoxin in type 2 immunity in asthma.C5a过敏毒素在哮喘2型免疫中的调节作用。
J Clin Invest. 2006 Mar;116(3):783-96. doi: 10.1172/JCI26582.
10
Regulation and function of anaphylatoxins and their receptors in allergic asthma.过敏毒素及其受体在过敏性哮喘中的调节作用与功能
Mol Immunol. 2017 Apr;84:51-56. doi: 10.1016/j.molimm.2016.11.013.

引用本文的文献

1
Complement's involvement in allergic Th2 immunity: a cross-barrier perspective.补体在过敏性Th2免疫中的作用:跨屏障视角
J Clin Invest. 2025 May 1;135(9). doi: 10.1172/JCI188352.
2
Clinical and Pathophysiological Tangles Between Allergy and Autoimmunity: Deconstructing an Old Dichotomic Paradigm.过敏与自身免疫之间的临床及病理生理纠葛:解构旧有的二分法范式
Clin Rev Allergy Immunol. 2025 Feb 11;68(1):13. doi: 10.1007/s12016-024-09020-3.
3
Distinctive CD39CD9 lung interstitial macrophages suppress IL-23/Th17-mediated neutrophilic asthma by inhibiting NETosis.

本文引用的文献

1
Allergic sensitization through the airway primes Th17-dependent neutrophilia and airway hyperresponsiveness.通过气道发生的变应性致敏引发Th17细胞依赖性中性粒细胞增多和气道高反应性。
Am J Respir Crit Care Med. 2009 Oct 15;180(8):720-30. doi: 10.1164/rccm.200904-0573OC. Epub 2009 Aug 6.
2
Th17 cells in rheumatoid arthritis and systemic lupus erythematosus.类风湿关节炎和系统性红斑狼疮中的辅助性T细胞17
J Intern Med. 2009 Jun;265(6):644-52. doi: 10.1111/j.1365-2796.2009.02099.x.
3
The TRAF1-C5 region on chromosome 9q33 is associated with multiple autoimmune diseases.
CD39CD9 肺间质巨噬细胞通过抑制 NETosis 抑制 IL-23/Th17 介导的中性粒细胞性哮喘。
Nat Commun. 2024 Oct 4;15(1):8628. doi: 10.1038/s41467-024-53038-2.
4
Molecular Pathways and Potential Therapeutic Targets of Refractory Asthma.难治性哮喘的分子途径及潜在治疗靶点
Biology (Basel). 2024 Aug 1;13(8):583. doi: 10.3390/biology13080583.
5
IL-13 and IL-17A activate β1 integrin through an NF-kB/Rho kinase/PIP5K1γ pathway to enhance force transmission in airway smooth muscle.IL-13 和 IL-17A 通过 NF-κB/Rho 激酶/PIP5K1γ 通路激活 β1 整合素,从而增强气道平滑肌中的力传递。
Proc Natl Acad Sci U S A. 2024 Aug 20;121(34):e2401251121. doi: 10.1073/pnas.2401251121. Epub 2024 Aug 13.
6
Role of Complement Components in Asthma: A Systematic Review.补体成分在哮喘中的作用:一项系统评价
J Clin Med. 2024 May 22;13(11):3044. doi: 10.3390/jcm13113044.
7
Gut Microbiota-Derived Tryptophan Metabolites Alleviate Allergic Asthma Inflammation in Ovalbumin-Induced Mice.肠道微生物群衍生的色氨酸代谢产物减轻卵清蛋白诱导小鼠的过敏性哮喘炎症
Foods. 2024 Apr 26;13(9):1336. doi: 10.3390/foods13091336.
8
Gene editing in allergic diseases: Identification of novel pathways and impact of deleting allergen genes.基因编辑在过敏性疾病中的应用:新型通路的鉴定和过敏原基因缺失的影响。
J Allergy Clin Immunol. 2024 Jul;154(1):51-58. doi: 10.1016/j.jaci.2024.03.016. Epub 2024 Mar 29.
9
Targeting Common Inflammatory Mediators in Experimental Severe Asthma and Acute Lung Injury.针对实验性重症哮喘和急性肺损伤中的常见炎症介质
Pharmaceuticals (Basel). 2024 Mar 5;17(3):338. doi: 10.3390/ph17030338.
10
Adjuvant effect of inhaled particulate matter containing free radicals following house-dust mite induction of asthma in mice.屋尘螨诱发小鼠哮喘后,吸入含自由基的颗粒物的佐剂效应。
Inhal Toxicol. 2023 Dec;35(13-14):333-349. doi: 10.1080/08958378.2023.2289024. Epub 2023 Dec 13.
9q33 染色体上的 TRAF1-C5 区域与多种自身免疫性疾病有关。
Ann Rheum Dis. 2010 Apr;69(4):696-9. doi: 10.1136/ard.2008.106567. Epub 2009 May 10.
4
Th17 Cells in MS and Experimental Autoimmune Encephalomyelitis.多发性硬化症和实验性自身免疫性脑脊髓炎中的Th17细胞
Int MS J. 2009 Apr;16(1):12-8.
5
A functional IL-13 receptor is expressed on polarized murine CD4+ Th17 cells and IL-13 signaling attenuates Th17 cytokine production.功能性白细胞介素-13受体在极化的小鼠CD4+ Th17细胞上表达,且白细胞介素-13信号传导减弱Th17细胞因子的产生。
J Immunol. 2009 May 1;182(9):5317-21. doi: 10.4049/jimmunol.0803868.
6
T(H)17-associated cytokines (IL-17A and IL-17F) in severe asthma.严重哮喘中与辅助性T细胞17相关的细胞因子(白细胞介素-17A和白细胞介素-17F)
J Allergy Clin Immunol. 2009 May;123(5):1185-7. doi: 10.1016/j.jaci.2009.02.024. Epub 2009 Apr 10.
7
A protective role for C5a in the development of allergic asthma associated with altered levels of B7-H1 and B7-DC on plasmacytoid dendritic cells.C5a在与浆细胞样树突状细胞上B7-H1和B7-DC水平改变相关的过敏性哮喘发展中的保护作用。
J Immunol. 2009 Apr 15;182(8):5123-30. doi: 10.4049/jimmunol.0804276.
8
House dust mite allergen induces asthma via Toll-like receptor 4 triggering of airway structural cells.屋尘螨变应原通过Toll样受体4触发气道结构细胞诱发哮喘。
Nat Med. 2009 Apr;15(4):410-6. doi: 10.1038/nm.1946. Epub 2009 Mar 29.
9
Inhibition of Th17 cells regulates autoimmune diabetes in NOD mice.抑制Th17细胞可调节非肥胖糖尿病(NOD)小鼠的自身免疫性糖尿病。
Diabetes. 2009 Jun;58(6):1302-11. doi: 10.2337/db08-1113. Epub 2009 Mar 16.
10
Allergen uptake, activation, and IL-23 production by pulmonary myeloid DCs drives airway hyperresponsiveness in asthma-susceptible mice.肺部髓样树突状细胞摄取变应原、激活并产生白细胞介素-23,从而导致哮喘易感小鼠出现气道高反应性。
PLoS One. 2008;3(12):e3879. doi: 10.1371/journal.pone.0003879. Epub 2008 Dec 8.